Image

Liver Cancer Therapy Study - Now Enrolling

See if you qualify for a new therapy clinical trial

What is a liver cancer study trial?

Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Duis viverra et felis vitae commodo. Duis ornare bibendum dolor at pellentesque. Proin mattis, tellus ut ultricies facilisis, ante mi consectetur turpis, vel viverra sapien
Image alt
Image alt

How it works?

This study is evaluating AGX101, an investigational antibody-drug conjugate therapy for advanced solid tumors.

  • DecorativeHimenaeos Integer tellus ante, cursus ac sapien sed, varius dictum arcu.
  • DecorativeAptent taciti sociosqu ad litora torquent.
  • DecorativeSed mi dolor, pharetra sit amet
Bg gradient

Call 1800-9860-568

now to find out if you are eligible
Call Now
Image

Feature One

Class aptent taciti ad litora torquent per conubia nostra, per inceptos himenaeos. Duis viverra et felis vitae.
Image

Feature Two

Class aptent taciti ad litora torquent per conubia nostra, per inceptos himenaeos. Duis viverra et felis vitae.
Image

Feature Three

Class aptent taciti ad litora torquent per conubia nostra, per inceptos himenaeos. Duis viverra et felis vitae.
Image

Feature Four

Class aptent taciti ad litora torquent per conubia nostra, per inceptos himenaeos. Duis viverra et felis vitae.
Image

Feature Five

Class aptent taciti ad litora torquent per conubia nostra, per inceptos himenaeos. Duis viverra et felis vitae.
Image

Feature Six

Class aptent taciti ad litora torquent per conubia nostra, per inceptos himenaeos. Duis viverra et felis vitae.
BG Tringle

Check your eligibility

Take up this questionnaire to help us determine if you have symptoms that are common to this clinical study. if you have the common symptoms, you may be eligible to take part in the study.
Start Answering

Your journey

Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Duis viverra et felis
01

Receiving the medication

You would receive entanercept (Enbrel) twice a week for 12 weeks and then once a week for 12 weeks. Etanercept as well as study related medical care is provided at no cost.
02

Visiting the study site

Study participation involves approximately 8 visits to your local study center over 6 to 7 months.
03

Follow-up

There would also be a follow-up telephone call 30 days after completing the study. No visits are required after participation is complete.
Bg gradient

Call 1800-9860-568

now to find out if you are eligible
Call Now